SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000819050-21-000170
Filing Date
2021-11-09
Accepted
2021-11-09 16:16:36
Documents
54
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bbi-20210930.htm   iXBRL 10-Q 1227167
2 EX-10.2 a2021093010qex102.htm EX-10.2 107882
3 EX-31.1 a2021093010qex311.htm EX-31.1 10114
4 EX-31.2 a2021093010qex312.htm EX-31.2 9843
5 EX-32.1 a2021093010qex321.htm EX-32.1 8920
  Complete submission text file 0000819050-21-000170.txt   4661902

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20210930.xsd EX-101.SCH 33221
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20210930_cal.xml EX-101.CAL 36737
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20210930_def.xml EX-101.DEF 146272
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20210930_lab.xml EX-101.LAB 379904
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20210930_pre.xml EX-101.PRE 243493
11 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20210930_htm.xml XML 570367
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21088 | Film No.: 211392416
SIC: 2836 Biological Products, (No Diagnostic Substances)